CIK 0001420720
- Non-accelerated filer
- Smaller reporting company
iBio, Inc.
Sign in to watch- Ticker
- IBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 262797813
- Phone
- +1 302-355-0650
- Business address
- 600 MADISON AVENUE, SUITE 1601, NEW YORK, NY, 10022-1737
- Former names
- iBio, Inc., iBioPharma, Inc., InB:Biotechnologies, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-02-20 | Chang Glenn Director | Returned to the company · Stock Option (right to buy) | −6,000 | 36,750 | ||
| 2019-02-20 | Chang Glenn Director | Grant or award · Stock Option (right to buy) | +4,500 | 36,750 | ||
| 2019-02-20 | TERENCE RYAN E Chief Scientific Officer | Returned to the company · Stock Option (right to buy) | −10,000 | 22,500 | ||
| 2019-02-20 | TERENCE RYAN E Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +7,500 | 22,500 | ||
| 2019-02-20 | TERENCE RYAN E Chief Scientific Officer | Returned to the company · Stock Option (right to buy) | −10,000 | 22,500 | ||
| 2019-02-20 | TERENCE RYAN E Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +7,500 | 22,500 | ||
| 2019-02-20 | TERENCE RYAN E Chief Scientific Officer | Returned to the company · Stock Option (right to buy) | −10,000 | 22,500 | ||
| 2019-02-20 | TERENCE RYAN E Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +7,500 | 22,500 | ||
| 2019-02-20 | Mullaney James P. Chief Financial Officer | Returned to the company · Stock Option (right to buy) | −15,000 | 11,250 | ||
| 2019-02-20 | Mullaney James P. Chief Financial Officer | Grant or award · Stock Option (right to buy) | +11,250 | 11,250 | ||
| 2019-01-01 | DART KENNETH BRYAN 10% owner | Other disposition | −1 | 1 | ||
| 2018-07-12 | Eastern Capital LTD 10% owner | Purchase | +2,200,000 | $0.90 | $2.0M | 8,457,734 |
| 2018-06-26 | Eastern Capital LTD 10% owner | Purchase | +1,683,334 | $0.90 | $1.5M | 6,257,734 |
| 2018-06-26 | Eastern Capital LTD 10% owner | Purchase · Series B Preferred Shares | +5,785 | $1,000.00 | $5.8M | 5,785 |
| 2017-11-30 | Eastern Capital LTD 10% owner | Purchase | +12,000,000 | $0.20 | $2.4M | 45,744,000 |
| 2017-05-01 | ERWIN ROBERT L President | Grant or award · Stock Option (right to buy) | +300,000 | $0.40 | $120K | 3,350,000 |
| 2017-05-01 | Kay Robert Executive Chairman and CEO | Grant or award · Stock Option (right to buy) | +300,000 | $0.40 | $120K | 4,350,000 |
| 2017-05-01 | FLUG SEYMOUR Director | Grant or award · Stock Option (right to buy) | +60,000 | $0.40 | $24K | 340,000 |
| 2017-05-01 | Elliott Arthur Y Director | Grant or award · Stock Option (right to buy) | +60,000 | $0.40 | $24K | 460,000 |
| 2017-05-01 | RUSSELL PHILIP K. Director | Grant or award · Stock Option (right to buy) | +60,000 | $0.40 | $24K | 460,000 |
Page 15 of 22 · 423 trades